**Specifications Table**TableSubject areaBiologyMore specific subject areaTargeted mass-spectrometric proteome profiling of liver and HepG2 cell lineType of dataFigure, table, raw files (.d), skyline files (.sky)How data was acquiredProteome profiling was performed using stable isotope-labeled standards (SRM/SIS) for liver tissue and HepG2 cellsData formatRawExperimental factorsThe trypsin digestion was used.Experimental featuresDigested samples were separated using the HPLC Agilent 1290 system including pump and autosampler. Internal Standard were produced using Overture (Protein Technologies, USA) or Hamilton Microlab STAR devices. The quantitative SRM analysis was performed using Agilent 6495 Triple Quadrupole (Agilent, USA) equipped with Jet Stream ionization source.Data source locationInstitute of Biomedical Chemistry, Moscow, RussiaData accessibilityData is available within this article and at the ProteomeXchange via PASSEL (http://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=[PXD004407](pride:PXD004407){#ir0005}).

**Value of the data**•This data characterizes the diversity of chromosome 18 protein species in liver tissue and HepG2 cell line using SRM.•This data could be of interest to laboratories studying protein reference levels and cross-tissue biological variability of proteome.•This data could be useful for protein, peptide and transition selection for SRM-assay development.•Dataset may be used as a test for automated SRM-data processing algorithms.

1. Data {#s0005}
=======

This dataset describes conditions of liver tissue and HepG2 cell line proteome profiling. Targeted protein list included 268 proteins of chromosome 18. Data were automatically processed to quantify proteins in the biosample. Dataset includes raw data, transition list, skyline files and sample preparation instructions, available in PASSEL, 2 figures and [Supplementary table](#s0045){ref-type="fn"} with protein copy numbers in liver tissue and HepG2 cell line.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Sample preparation {#s0015}
-----------------------

The trypsin digestion of liver tissue and cell lysates was performed as described in Ponomarenko et al. [@bib2].

2.2. Peptide synthesis {#s0020}
----------------------

The peptides were produced using the SOLiD-phase peptide synthesis on the Overture (Protein Technologies, USA) or Hamilton Microlab STAR devices according to the method published in Hood et al. [@bib4] . The isotope-labeled leucine (Fmoc--Leu--OH-13C6,15N) was used for isotope-labeled peptide synthesis instead of the unlabeled leucine (Fmoc--Leu--OH) [@bib5].

2.3. Transition list {#s0025}
--------------------

List of peptides for 268 chromosome 18 proteins was generated manually using data about occurrence of proteotypic peptides from proteomic repositories GPMdb, ProteinAtlas and PRIDE and MaRiMba-criteria (protocol was described earlier in Supplementary note 2, Zgoda et al. [@bib1]). For each protein one "best-flyer" peptide was chosen. For each peptide 3 the most intensive transitions [@bib6] were chosen using previous research results.

All 268 peptides were distributed over 3 SRM-assays (A--C) in equal parts according to their calculated retention time to avoid interference.

*LC-SRM Analysis* was held as described earlier in Supplementary note 2, Zgoda et al. [@bib1]. Each SRM experiment was repeated in 3 technical runs. Each transition peak was characterized with the following variables: retention time, peak height, SIS/endogenous peak area ratio. No manual inspection for to find transitions that were similar to those in the target peptides or to reveal detected peptides was held.

2.4. How to use data {#s0030}
--------------------

Dataset is represented by several file types ([Fig. 1](#f0005){ref-type="fig"}). For re-using of the dataset and extraction relevant information from it one can install freely-available and open source Windows client application Skyline [@bib7] (for each biosample there is one skyline file, including transitions and technical runs info). It provides an opportunity to open raw data, visualize ([Fig. 2](#f0010){ref-type="fig"}) and analyze SRM data. Besides it is possible to use proprietary software (Agilent MassHunter Workstation Software) for data visualization.

All raw file are named using the following template:1)Chromosome number: *X18;*2)Sample type : *HLV* (liver tissue) or *HPG* (HepG2 cell line);3)SRM-assay id: *A, B* or *C*; and4)Technical run number: *roo1, r002, r003.*

For example, raw file name *X18HPG_C-r002.d* ([Fig. 2](#f0010){ref-type="fig"}). Skyline files also are named using these keys.

2.5. Quantification {#s0035}
-------------------

Calibration curves were obtained for each of the desired peptides using the mixtures of purified synthetic non-labeled peptides in the concentration range of 100--100 fmole/µl and its isotopically labeled standards (SIS) were added at the concentration of 2 fmole/µl. All calibration curves were linear in the range of 100--0.1 fmole/µl and showed the coefficient of linear regression equal to 0.95.

Prior to the sample processing, the performance of the LC-SRM platforms used was validated by obtaining the calibration curves of the corresponding set of SIS and synthetic non-labeled peptides. Moreover, after five LC-SRM runs we verified the relevance of calibration by analyzing one of the calibration peptide solution at 10 fmole/µl.

The detection limit was defined as the lowest concentration determined on the linear part of calibration curve. It varies for different peptides in the range from 100 amole/µl to 200 amole/µl.

Labeled (SIS)/target peptide peak area ratios were used to calculate the concentration of the targeted peptide in a sample. Peak area ratios were obtained using Skyline software.

C~pept~ =C~lab~\*S~pept~/S~lab~ where C~pept~ -- target peptide concentration, C~lab~ -- labeled peptide (SIS) concentration (see *Quantification*), S~pept~ -- area of target peptide peak, and S~lab~ -- area of labeled peptide peak.

All calculated target peptide copy numbers for liver tissue and HepG2 are listed in the [Supplementary Table 1](#s0060){ref-type="sec"}.
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